Occurrence and human health risk of wastewater-derived pharmaceuticals in a drinking water source for Shanghai, East China

Science of the Total Environment

Volumn 490, Issue , 2014, Pages 987-993

  Wen, Zhi Hao ^a   Chen, Ling ^a   Meng, Xiang Zhou ^a   Duan, Yan Ping ^a   Zhang, Zeng Sheng ^c   Zeng, Eddy Y ^b  

^a TONGJI UNIVERSITY   (China)

^b GUANGZHOU INSTITUTE OF GEOCHEMISTRY   (China)

^c Tongji Environmental Protection Co Ltd   (China)

Author keywords

Drinking water; Huangpu River; Human health risk; Pharmaceuticals; Shanghai

Indexed keywords

DRUG PRODUCTS; HEALTH; HEALTH RISKS; POTABLE WATER; VETERINARY MEDICINE;

AQUATIC ENVIRONMENTS; DRINKING WATER SOURCES; HUANGPU RIVER; HUMAN HEALTH RISKS; PHARMACEUTICAL RESIDUES; RISK TO HUMAN HEALTH; SEASONAL VARIATION; SHANGHAI;

RIVERS;

CLOFIBRIC ACID; DICLOFENAC; DRINKING WATER; IBUPROFEN; KETOPROFEN; NAPROXEN; DRUG; WASTE WATER; WATER POLLUTANT;

DRINKING WATER; DRUG; ENVIRONMENTAL RISK; HEALTH IMPACT; HEALTH RISK; POLLUTION EXPOSURE; RIVER POLLUTION; SEASONAL VARIATION; SPATIAL DISTRIBUTION; WATER QUALITY; WATER SUPPLY;

AQUATIC ENVIRONMENT; ARTICLE; CHINA; CONCENTRATION (PARAMETERS); HEALTH HAZARD; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; PRIORITY JOURNAL; RISK ASSESSMENT; RIVER; SEASONAL VARIATION; WASTE WATER; WASTE WATER MANAGEMENT; WATER ANALYSIS; WATER CONTAMINATION; WATER QUALITY; WATER SUPPLY; ANALYSIS; CHEMISTRY; ENVIRONMENTAL MONITORING; STATISTICS AND NUMERICAL DATA; WATER POLLUTANT;

CHINA; HUANGPU RIVER; SHANGHAI;

CHINA; DRINKING WATER; ENVIRONMENTAL MONITORING; HUMANS; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; WASTE WATER; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 84902005649     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2014.05.087     Document Type: Article

References (28)

1. Bendz D., Paxeus N.A., Ginn T.R., Loge F.J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. J Hazard Mater 2005, 122:195-204.
2. Boxall A.B.A., Rudd M.A., Brooks B.W., Caldwell D.J., Choi K., Hickmann S., et al. Pharmaceuticals and personal care products in the environment: What are the big questions?. Environ Health Perspect 2012, 120:1221-1229.
3. Bruce G.M., Pleus R.C., Snyder S.A. Toxicological relevance of pharmaceuticals in drinking water. Environ Sci Technol 2010, 44:5619-5626.
4. Chen H., Li X.J., Zhu S.C. Occurrence and distribution of selected pharmaceuticals and personal care products in aquatic environments: A comparative study of regions in China with different urbanization levels. Environ Sci Pollut Res 2012, 19:2381-2389.
5. Cleuvers M. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol Environ Saf 2004, 59:309-315.
6. Deo R.P., Halden R.U. Pharmaceuticals in the built and natural water environment of the United States. Water 2013, 5:1346-1365.
7. Duan Y.P., Meng X.Z., Wen Z.H., Chen L. Acidic pharmaceuticals in domestic wastewater and receiving water from hyper-urbanization city of China (Shanghai): Environmental release and ecological risk. Environ Sci Pollut Res 2013, 20:108-116.
8. Duan Y.P., Meng X.Z., Wen Z.H., Ke R.H., Chen L. Multi-phase partitioning, ecological risk and fate of acidic pharmaceuticals in a wastewater receiving river: The role of colloids. Sci Total Environ 2013, 447:267-273.
9. Gallo P., Fabbrocino S., Vinci F., Fiori M., Danese V., Nasi A., et al. Multi-residue determination of non-steroidal anti-inflammatory drug residues in animal serum and plasma by HPLC and photo-diode array detection. J Chromatogr Sci 2006, 44:585-590.
10. Hughes S.R., Kay P., Brown L.E. Global synthesis and critical evaluation of pharmaceutical data sets collected from river systems. Environ Sci Technol 2013, 47:661-677.
11. Jiang L., Hu X.L., Yin D.Q., Zhang H.C., Yu Z.Y. Occurrence, distribution and seasonal variation of antibiotics in the Huangpu River, Shanghai, China. Chemosphere 2011, 82:822-828.
12. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: A national reconnaissance. Environ Sci Technol 2002, 36:1202-1211.
13. Leung H.W., Jin L., Wei S., Tsui M.M., Zhou B., Jiao L., et al. Pharmaceuticals in tap water: human health risk assessment and proposed monitoring framework in China. Environ Health Perspect 2013, 121:839-846.
14. Liu J.L., Wong M.H. Pharmaceuticals and personal care products (PPCPs): A review on environmental contamination in China. Environ Int 2013, 59:208-224.
15. Nikolaou A., Meric S., Fatta D. Occurrence patterns of pharmaceuticals in water and wastewater environments. Anal Bioanal Chem 2007, 387:1225-1234.
16. Oaks J.L., Gilbert M., Virani M.Z., Watson R.T., Meteyer C.U., Rideout B.A., et al. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 2004, 427:630-633.
17. Peng X.Z. China's demographic history and future challenges. Science 2011, 333:581-587.
18. Peng X.Z., Yu Y.J., Tang C.M., Tan J.H., Huang Q.X., Wang Z.D. Occurrence of steroid estrogens, endocrine-disrupting phenols, and acid pharmaceutical residues in urban riverine water of the Pearl River Delta, South China. Sci Total Environ 2008, 397:158-166.
19. Rehman M.S., Rashid N., Ashfaq M., Saif A., Ahmad N., Han J.I. Global risk of pharmaceutical contamination from highly populated developing countries. Chemosphere 2013, (in press). 10.1016/j.chemosphere.2013.02.036.
20. Rivera-Utrilla J., Sánchez-Polo M., Ferro-García M.Á., Prados-Joya G., Ocampo-Pérez R. Pharmaceuticals as emerging contaminants and their removal from water. A review. Chemosphere 2013, 93:1268-1287.
21. Schwab B.W., Hayes E.P., Fiori J.M., Mastrocco F.J., Roden N.M., Cragin D., et al. Human pharmaceuticals in US surface waters: A human health risk assessment. Regul Toxicol Pharmacol 2005, 42:296-312.
22. Segura P.A., Francois M., Gagnon C., Sauve S. Review of the occurrence of anti-infectives in contaminated wastewaters and natural and drinking Waters. Environ Health Perspect 2009, 117:675-684.
23. Sui Q., Wang B., Zhao W.T., Huang J., Yu G., Deng S.B., et al. Identification of priority pharmaceuticals in the water environment of China. Chemosphere 2012, 89:280-286.
24. USEPA Exposure factors handbook 2009, The United States Environmental Protection Agency, Washington, DC.
25. Vieno N.M., Tuhkanen T., Kronberg L. Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ Sci Technol 2005, 39:8220-8226.
26. Wang L., Ying G.G., Zhao J.L., Yang X.B., Chen F., Tao R., et al. Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of north China. Sci Total Environ 2010, 408:3139-3147.
27. Williams E.S., Brooks B.W. Human pharmaceuticals in the environment: current and future perspectives 2012, Springer.
28. Zhao J.L., Ying G.G., Liu Y.S., Chen F., Yang J.F., Wang L., et al. Occurrence and a screening-level risk assessment of human pharmaceuticals in the Pearl River system, South China. Environ Toxicol Chem 2010, 29:1377-1384.